These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24190591)
1. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells. Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591 [TBL] [Abstract][Full Text] [Related]
2. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation. Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma. Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933 [TBL] [Abstract][Full Text] [Related]
4. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792 [TBL] [Abstract][Full Text] [Related]
5. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas. Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511 [TBL] [Abstract][Full Text] [Related]
6. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
7. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells. Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377 [TBL] [Abstract][Full Text] [Related]
10. Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma. Cui Z; Zhang L; Hua Z; Cao W; Feng W; Liu Z Oncol Rep; 2007 Apr; 17(4):829-33. PubMed ID: 17342323 [TBL] [Abstract][Full Text] [Related]
11. [Expression of SLP-2 protein in esophageal squamous cell carcinoma is associated with cancer invasion]. Cao WF; Zhang LY; Zhang B; Wang YQ; Liu ZH; Sun BC Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):830-3. PubMed ID: 21223688 [TBL] [Abstract][Full Text] [Related]
12. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival. Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491 [TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma. Matoba H; Sugano S; Yamaguchi N; Miyachi Y Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670 [TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217 [TBL] [Abstract][Full Text] [Related]
16. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases. Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959 [TBL] [Abstract][Full Text] [Related]
18. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma. Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Geraldo MV; Yamashita AS; Kimura ET Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046 [TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]